Revelation Biosciences (NASDAQ:REVB) Trading 2.8% Higher – Should You Buy?

Revelation Biosciences, Inc. (NASDAQ:REVB)’s share price shot up 2.8% during trading on Tuesday . The stock traded as high as $4.54 and last traded at $4.40. 83,958 shares were traded during trading, a decline of 76% from the average session volume of 352,171 shares. The stock had previously closed at $4.28.

Revelation Biosciences Stock Up 2.8 %

The stock’s 50 day moving average price is $5.88 and its two-hundred day moving average price is $11.16. The firm has a market capitalization of $1.19 million, a price-to-earnings ratio of -0.02 and a beta of 0.19.

Revelation Biosciences Company Profile

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.